POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to tame painful muscle condition and reduce steroid dependence
Disease control CompletedThis study tested whether adding an injectable drug called secukinumab to standard steroid treatment helps people with polymyalgia rheumatica (PMR) who recently experienced a symptom flare-up. It involved 381 adults aged 50+ who received either the drug or a placebo alongside a t…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope to ditch steroids for painful muscle condition
Disease control CompletedThis study tested if a drug called Rituximab could help people newly diagnosed with polymyalgia rheumatica (PMR) achieve remission without needing long-term steroid treatment. Steroids are the standard treatment but can have serious side effects. The trial compared Rituximab agai…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First look: testing a new IV treatment for painful inflammatory diseases
Knowledge-focused CompletedThis study aimed to understand how the body processes a drug called secukinumab when given through an IV (intravenous) line, and to check its safety. It involved 65 adults with either giant cell arteritis (GCA) or polymyalgia rheumatica (PMR), two painful inflammatory conditions.…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC